Evidence map›Paper›PMID 33747450›Full record

ArticleFood science & nutrition2021

Camel milk as an alternative treatment regimen for diabetes therapy.

Humaira Hussain, Feroza Hamid Wattoo, Muhammad Hamid Sarwar Wattoo, Muhammad Gulfraz, Tariq Masud, Imam Shah, Sakhawat Ali, Seyed Ebrahim Alavi

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Camel Milk in Skin Cancer Therapeutics: AnAnti-cancer agents in medicinal chemistry · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Fortification of Fermented Camel Milk withMolecules (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Humaira HussainUniversity Institute of Biochemistry and Biotechnology PMAS - Arid Agriculture University Rawalpindi Pakistan.
Feroza Hamid WattooUniversity Institute of Biochemistry and Biotechnology PMAS - Arid Agriculture University Rawalpindi Pakistan.ORCID https://orcid.org/0000-0002-2823-0655
Muhammad Hamid Sarwar WattooDepartment of Chemistry Pakistan Institute of Engineering and Applied Sciences Islamabad Pakistan.
Muhammad GulfrazUniversity Institute of Biochemistry and Biotechnology PMAS - Arid Agriculture University Rawalpindi Pakistan.
Tariq MasudDepartment of Food Technology PMAS - Arid Agriculture University Rawalpindi Pakistan.
Imam ShahNational Veterinary Laboratories Islamabad Pakistan.
Sakhawat AliNational Veterinary Laboratories Islamabad Pakistan.
Seyed Ebrahim AlaviDepartment of Pilot Nanobiotechnology Pasteur Institute of Iran Tehran Iran.
Pir Mehr Ali Shah Arid Agriculture University · PKPakistan Institute of Engineering and Applied Sciences · PKPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camel milk is a valuable source of nutrition with a wide range of therapeutic effects. Its unique composition helps to regulate the blood glucose level. The current study is aimed to evaluate the antidiabetic and hepatoprotective effects, as well as lipid profile restoration of camel milk in the diabetic mouse model. This innovative study evaluates the therapeutic effects of camel milk in diabetic mice by simultaneous measurement of blood glucose, HbA1c, ALT, AST, TG, cholesterol, and histopathological studies. The results showed that camel milk has significantly reduced blood glucose, HbA1c (

Indexed as

antidiabetic activityglibenclamidehepatoprotective effecttriglyceride

Identifiers

PMID33747450
PMCPMC7958562
OpenAlexW3127614389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.